These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 4462247

  • 1. Bilateral amyloidosis of the vitreous body without systemic involvement.
    Lieberman TW, Ferry AP.
    Trans Am Ophthalmol Soc; 1974; 72():302-28. PubMed ID: 4462247
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Adherences between the crystalline lens and the vitreous body].
    Rodriguez Caballero ML, Nordmann J.
    Bull Soc Ophtalmol Fr; 1973; 73(9-10):967-71. PubMed ID: 4803202
    [No Abstract] [Full Text] [Related]

  • 6. Recurrent amyloid involvement in the virreous body after vitrectomy.
    Irvine AR, Char DH.
    Am J Ophthalmol; 1976 Nov; 82(5):705-8. PubMed ID: 998692
    [Abstract] [Full Text] [Related]

  • 7. Vitreous amyloidosis. Case report.
    Mieler WF, Williams DF, Levin M.
    Arch Ophthalmol; 1988 Jul; 106(7):881-3. PubMed ID: 3390045
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Ocular manifestations in systemic amyloidosis].
    Inomata H.
    Nihon Rinsho; 1991 Apr; 49(4):896-902. PubMed ID: 2072551
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical case of the month: non-familial vitreous amyloidosis].
    Tek A, Rakic JM.
    Rev Med Liege; 2013 Apr; 68(7-8):396-8. PubMed ID: 24053097
    [Abstract] [Full Text] [Related]

  • 11. [Isolated vitreous amyloidosis].
    Vermuso L, Gueudry J, Sauvêtre G, Piton N, Guerrot AM, Sturtz F, Portmann A, Muraine M.
    J Fr Ophtalmol; 2017 Jan; 40(1):e7-e9. PubMed ID: 28065461
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Ocular amyloidosis: clinical points learned from one case.
    Bene C, Kranias G.
    Ann Ophthalmol; 1990 Mar; 22(3):101-2. PubMed ID: 2331125
    [Abstract] [Full Text] [Related]

  • 15. Familial vitreous amyloidosis linked with factor V Leiden deficiency.
    Moortgat I, Van Ginderdeuren R, Van Calster J.
    Br J Ophthalmol; 2011 Dec; 95(12):1755, 1762. PubMed ID: 20805139
    [No Abstract] [Full Text] [Related]

  • 16. [Vitreous amyloidosis. Apropos of 2 cases with an ultrastructure study].
    Trepsat C, Hullo A, Durand L, Bouvier R.
    Bull Soc Ophtalmol Fr; 1984 Dec; 84(6-7):853-6. PubMed ID: 6534628
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A rare transthyretin mutation (Asp18Glu) associated with vitreous amyloid.
    Solano JM, Pulido JS, Salomao DR.
    Ophthalmic Genet; 2007 Jun; 28(2):73-5. PubMed ID: 17558848
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.